RobertVan BurenEmmonsMD

Hematology • Louisville, KY

Hematologic Oncology

University of Louisville

Join to view full profile

Dr. Emmons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Emmons' full profile

Already have an account?

Office
529 S Jackson St
Rm. 423
Louisville, KY 40202
Phone+1 502-562-4569

Fax+1 502-561-8694
Is this information wrong?

Summary

Dr. Robert Emmons is a hematologist in Louisville, KY. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 28 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1994
University of Michigan Health SystemResidency, Internal Medicine, 1989 - 1992
University of Cincinnati College of MedicineClass of 1989

Certifications & Licensure

KY State Medical License 2017 - 2025
LA State Medical License 2012 - 2020
PA State Medical License 2003 - 2012
MD State Medical License 1993 - 1998

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2013 Dec 01
Terminated
Phase 2
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
Active, not recruiting
Phase 3
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis
Hamza Hashmi, Shruti Bhandari, Rohit Kumar, Prashant Tripathi, Jill Rhodes, Lindsay Figg, Timothy Baize, Maxwell M. Krem, Mohamed M. Hegazi, Robert Emmons> ;Hematology/oncology and Stem Cell Therapy. 2020 Dec 1
1 citations
Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institu...
Hamza Hashmi, Shruti Bhandari, Jugraj Dhanoa, Xiaoyong Wu, Shesh N. Rai, Lindsay Figg, Timothy Baize, Maxwell M. Krem, Mohamed M. Hegazi, Robert Emmons> ;Cureus. 2020 Feb 5
3 citations
Rare case of Bing-Neel syndrome treated successfully with ibrutinib.
Hamza Hashmi, Jugraj Dhanoa, Robert Emmons> ;BMJ Case Reports. 2019 Jun 25
17 citations
Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant.
Christian Joseph Fidler, Thomas R. Klumpp, Mangan Kf, MaryEllen Martin, Manish Sharma, Robert Emmons, Meina Lu, Patricia Kropf> ;American Journal of Hematology. 2012 Feb 1
Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
W. Edward Jordan, Robert Emmons, Dan T. Vogl, Gloria J. Morris> ;Seminars in Oncology. 2011 Jun 1
Readers' Responses to "Cancer of Unknown Primary Site: Advances in Diagnostics"
Robert Emmons, Gloria J. Morris> ;Seminars in Oncology. 2010 Dec 1
2 citations
Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation.
Satish Shanbhag, Mitchell R. Smith, Robert Emmons> ;Stem Cells and Cloning. 2010 Jul 7
24 citations
Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with pro...
Agnieszka K. Witkiewicz, Thomas G. McConnell, Magdalena Potoczek, Robert Emmons, Robert J. Kurman> ;Human Pathology. 2010 Jan 1
13 citations
Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin.
Karen N. Wu, Robert Emmons, Michael P. Lisanti, John L. Farber, Agnieszka K. Witkiewicz> ;Cell Cycle. 2009 Nov 1
127 citations
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Jonathan R. Brody, Christina L. Costantino, Adam C. Berger, Takami Sato, Michael P. Lisanti, Charles J. Yeo, Robert Emmons, Agnieszka K. Witkiewicz> ;Cell Cycle. 2009 Jun 15
7 citations
Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
Baldeep Wirk, Thomas R. Klumpp, John Ulicny, Jay H. Herman, James Gajewski, Mary Ellen Martin, Robert Emmons, Mangan Kf> ;Transfusion. 2007 Sep 27
14 citations
Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; Conversion to full donor chimerism
Anand Jillella, Danielle Shafer, Thomas R. Klumpp, Robert V.B. Emmons, Mangan Kf> ;American Journal of Hematology. 2007 Jun 1
20 citations
Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
Thomas R. Klumpp, Jay H. Herman, John Ulicny, Robert Emmons, Mary Ellen Martin, Mangan Kf> ;Bone Marrow Transplantation. 2006 Sep 11
Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting.
Burt RK, Arnold R, Emmons R, Oyama Y, Marmont A> ;Bone Marrow Transplant.. 2003-08-01
42 citations
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy.
Karen K. Ballen, Pamela S. Becker, Robert Emmons, Thomas J. Fitzgerald, Chung C. Hsieh, Qin Liu, Christine Heyes, Yeteive Clark, William Levy, Jean Francois Lambert, F...> ;Blood. 2002 Jul 15
20 citations
Expression of interferon-γ by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity
Jian-Mei Yu, Robert V. B. Emmons, Yutaka Hanazono, Stephanie Sellers, Neal S. Young, Cynthia E. Dunbar> ;Experimental Hematology. 1999 May 1
139 citations
Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
Cynthia E. Dunbar, Donald B. Kohn, Raphael Schiffmann, Norman W. Barton, Jan A. Nolta, Joan A. Esplin, Michael Pensiero, Zhifeng Long, Chris Lockey, Robert V. B. Emmon...> ;Human Gene Therapy. 1998 Nov 20
88 citations
Green Fluorescent Protein Retroviral Vectors: Low Titer and High Recombination Frequency Suggest a Selective Disadvantage
Yutaka Hanazono, Jian-Mei Yu, Cynthia E. Dunbar, Robert V. B. Emmons> ;Human Gene Therapy. 1997 Jul 20
56 citations
Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve mark...
Robert V. B. Emmons, Sandra Doren, JoAnne Zujewski, Michele Cottler-Fox, Charles S. Carter, Kenneth Hines, Joyce A. O'Shaughnessy, Susan F. Leitman, J.J. Greenblatt, K...> ;Blood. 1997 Jun 1
18 citations
Transduction of hematopoietic stem cells in humans and in nonhuman primates
Cynthia E. Dunbar, John F. Tisdale, Jian Mei Yu, Toshihiro Soma, JoAnne Zujewski, David M. Bodine, Stephanie Sellers, Kenneth H. Cowan, Robert E. Donahue, Robert V. B....> ;Stem Cells. 1997 Apr 1
65 citations
Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
Cynthia E. Dunbar, Robert V. B. Emmons> ;Stem Cells. 1994 Jan 1
Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.
Reid I, Sharpe I, McDevitt J, Maxwell W, Emmons R, Tanner WA, Monson JR> ;Br. J. Cancer. 1991-11-01
Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.
Foncuberta, M. C., Cagnoni, P. J., Brandts, C. H., Mandanas, R., Fields, K., Derigs, H. G., Reed, E., Sonis, S. T., Fay, J., LeVeque, F., Pouillart, P., Schrezenmeier,...> ;J Immunother. 2001 Sep 22
343 citations
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
R. V. B. Emmons, Diane M. Reid, R. L. Cohen, G. Meng, Neal S. Young, Cynthia E. Dunbar, NR Shulman> ;Blood. 1996 May 15
Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma.
Maxwell, W., McDevitt, J., Reid, I., Sharpe, I., Feighery, C., Tanner, W. A., Emmons, R., Monson, J. R.> ;Eur J Surg Oncol. 1993 Jun
Join now to see all

Press Mentions

Liz Weston: How Gratitude Can Help Your Financial LifeOctober 4th, 2021
Does Practicing Gratitude Help Your Immune System?August 9th, 2021
If You Truly Value Your Time, Practice PatienceJuly 26th, 2021
Join now to see all